Estimating procedure volumes when published data is scarce
Most MedTech markets don't have clean, public procedure data. Here's how triangulation across registries, guidelines, and primary research produces reliable estimates.
Reliable market sizing rarely comes from a single source. In MedTech, procedure volumes must usually be reconstructed from epidemiology, care-pathway logic, and primary validation with clinicians.
We walk through a triangulated approach — combining top-down modelling with bottom-up, facility-level estimation — and how KOL interviews sharpen the assumptions that matter most.
Related services
Want to talk this through?
Tell us what decision you're facing. We'll turn it into a clear, evidence-backed answer.
